BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gordon CE, Balk EM, Francis JM. Summary of the 2018 Kidney Disease Improving Global Outcomes (KDIGO) Guideline on hepatitis C in chronic kidney disease. Semin Dial 2019;32:187-95. [PMID: 30496617 DOI: 10.1111/sdi.12768] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Erken E, Altunoren O, Gungor O. Poor management of hepatitis C infection will cause serious issues for patients with advanced chronic kidney disease. J Evid Based Med 2021;14:87-9. [PMID: 33988914 DOI: 10.1111/jebm.12433] [Reference Citation Analysis]
2 Bloom RD, Roth D. Introduction to hepatitis C virus infection in patients with kidney disease: A roadmap for nephrologists. Semin Dial 2019;32:91-2. [PMID: 30827039 DOI: 10.1111/sdi.12775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Winston A, Wurcel AG, Gordon C, Goyal N. Viral hepatitis in patients on hemodialysis. Semin Dial 2020;33:254-62. [PMID: 32394502 DOI: 10.1111/sdi.12882] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Nevola R, Rinaldi L, Zeni L, Sasso FC, Pafundi PC, Guerrera B, Marrone A, Giordano M, Adinolfi LE. Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct-acting antivirals. JGH Open. 2020;4:713-721. [PMID: 32782961 DOI: 10.1002/jgh3.12324] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Li C, Liang J, Xiang H, Chen H, Tian J. Effectiveness of direct-acting antivirals in maintenance hemodialysis patients complicated with chronic hepatitis C. Medicine (Baltimore) 2020;99:e23384. [PMID: 33235113 DOI: 10.1097/MD.0000000000023384] [Reference Citation Analysis]
6 Su Z, Jin Y, Zhang Y, Guan Z, Li H, Chen X, Xie C, Zhang C, Liu X, Li P, Ye P, Zhang L, Kong Y, Luo W. The Diagnostic and Prognostic Potential of the B-Cell Repertoire in Membranous Nephropathy. Front Immunol 2021;12:635326. [PMID: 34122405 DOI: 10.3389/fimmu.2021.635326] [Reference Citation Analysis]
7 Alkadi MM, Abuhelaiqa EA, Elshirbeny MF, Hamdi AF, Fituri OM, Asim M, Alkaabi SR, Derbala MF, Jarman ME, Ashour AM, Nauman A, Al Maslamani YK, Butt AA, Al-Malki HA. Eradication of hepatitis C virus infection in kidney transplant recipients using direct-acting antiviral therapy: Qatar experience. Immun Inflamm Dis 2021;9:246-54. [PMID: 33264509 DOI: 10.1002/iid3.386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Alcalde-bezhold G, Alcázar-arroyo R, Angoso-de-guzmán M, Arenas MD, Arias-guillén M, Arribas-cobo P, Díaz-gómez JM, García-maset R, González-parra E, Hernández-marrero D, Herrero-calvo JA, Maduell F, Molina P, Molina-núñez M, Otero-gonzález A, Pascual J, Pereira-garcía M, Pérez-garcía R, Dolores del Pino y Pino M, Prieto-velasco M, Pulido JFP, Sánchez-álvarez JE, Sánchez-hernández R, de Sequera-ortiz P. Hemodialysis Centers Guide 2020. Nefrología (English Edition) 2021;41:1-77. [DOI: 10.1016/s2013-2514(22)00042-6] [Reference Citation Analysis]
9 Zhang Y, Jin Y, Guan Z, Li H, Su Z, Xie C, Chen X, Liu X, Pan Y, Ye P, Zhang L, Kong Y, Luo W. The Landscape and Prognosis Potential of the T-Cell Repertoire in Membranous Nephropathy. Front Immunol 2020;11:387. [PMID: 32210970 DOI: 10.3389/fimmu.2020.00387] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]